GB
Therapeutic Areas
Sanuwave Pipeline
| Drug | Indication | Phase |
|---|---|---|
| UltraMIST® Therapy System | Chronic, Non-Healing Wounds (Diabetic Foot Ulcers, Venous Leg Ulcers, Pressure Ulcers) | Commercial |
Leadership Team at Sanuwave
MF
Morgan Frank
Chief Executive Officer & Chairman of the Board
PS
Peter Sorensen
Chief Financial Officer
DL
Dustin Libby
Executive Vice President of Commercial Operations
TW
Tim Wern
Executive Vice President of Sales – U.S. Wound
JT
Jim Tyler
Director
IM
Ian Miller
Director
JB
Jeffrey Blizard
Director